All News | Page 2 of 7

top of page

Subscribe to our newsletter

News

Categories

Sign up

Featured Posts

How Israeli technology saved 78-year-old Leah from skin cancer

How Israeli technology saved 78-year-old Leah from skin cancer

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha DaRT treatment proves a success in first-in-human trial

Alpha DaRT treatment proves a success in first-in-human trial

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

Archive

Follow Us

Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™

Jun 23, 2022

Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™

JERUSALEM, June 22, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...

Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site

Jun 16, 2022

Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site

Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended...

FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC

Jun 8, 2022

FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC

JERUSALEM, June 8, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the "Company"), the developer of the...

Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors

Jun 8, 2022

Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors

JERUSALEM, June 7, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the...

Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 26, 2022

Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update

-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $104 million in gross proceeds-...

Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update

Mar 28, 2022

Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update

-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds-...

Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors

Mar 22, 2022

Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors

JERUSALEM, March 21, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

Mar 8, 2022

Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

Alpha Tau Is Expected to Commence Trading on Nasdaq Under the Ticker "DRTS" on March 8, 2022 JERUSALEM and WILMINGTON, Del., March 7,...

New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer

Jan 20, 2022

New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer

JERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...

Results of First US Clinical Trial of Alpha DaRT™

Jan 10, 2022

Results of First US Clinical Trial of Alpha DaRT™

Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...

2

3 4 5

bottom of page